Jing Ji
Chief Tech/Sci/R&D Officer presso ABBISKO CAYMAN LIMITED
Profilo
Jing Ji is currently the Chief Medical Officer at Abbisko Cayman Ltd.
Prior to this, he held the position of Vice President at AstraZeneca PLC from 2015 to 2020, Head-Medical Affairs at GSK Plc from 2006 to 2010, Manager-Clinical Development at Sanofi SA from 2003 to 2005, and Manager-Clinical Research at Merck Sharp & Dohme (China) Ltd.
from 1997 to 2003.
He also briefly served as Senior VP-Medical & Clinical Development at Shanghai Lianbio Development Co., Ltd.
from 2020 to 2021.
Dr. Ji received his undergraduate and graduate degrees from Fudan University in 1993 and 1995, respectively, and his graduate degree from Shanghai Second Medical University in 1995.
Posizioni attive di Jing Ji
| Società | Posizione | Inizio |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Precedenti posizioni note di Jing Ji
| Società | Posizione | Fine |
|---|---|---|
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/05/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/01/2010 |
| Sanofi SA | Corporate Officer/Principal | 01/09/2005 |
| Merck Sharp & Dohme (China) Ltd. | Corporate Officer/Principal | 01/03/2003 |
Formazione di Jing Ji
| Fudan University | Undergraduate Degree |
| Shanghai Second Medical University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GSK PLC | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
| Sanofi SA | Health Technology |
| Merck Sharp & Dohme (China) Ltd. | |
Shanghai Lianbio Development Co., Ltd.
Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Health Technology |
- Borsa valori
- Insiders
- Jing Ji
